Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

Details for Australian Patent Application No. 2006236508 (hide)

Owner Neogenix Oncology, Inc.

Inventors Tsang, Kwong Y.; Hollinshead, Ariel C.; Bristol, J. Andrew; Arlen, Myren

Agent Watermark

Pub. Number AU-B-2006236508

PCT Pub. Number WO2006/113546

Priority 60/671,481 15.04.05 US

Filing date 14 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 2 February 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/113546 Priority application(s): WO2006/113546

2 February 2012 Application Accepted

  Published as AU-B-2006236508

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236512-Viral nucleoprotein detection using an ion channel switch biosensor

2006236500-Corneal implants and methods of use